HDL metabolic activities in a boy with lipoprotein lipase deficiency and his family

European Journal of Clinical Investigation

Volumn 34, Issue 7, 2004, Pages 467-474

  Brites, F ^a   Verona, J ^a   Fernandez K ^a   Henriksen, F ^b   Fruchart, J ^c   Cesar, M ^c,d   Castro, G ^c   Wikinski, R ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c INSTITUT PASTEUR DE LILLE   (France)

^d HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

Hypertriglyceridaemia; Hypoalphalipoproteinaemia; Paraoxonase 1; Platelet activating factor acetylhydrolase; Reverse cholesterol transport; Two dimensional electrophoresis

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANTIOXIDANT; ARGININE; ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LEUCINE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SERINE; UNCLASSIFIED DRUG;

ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; EVALUATION; FAMILY; GENE MUTATION; GENETIC CONSERVATION; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; LIPOPROTEIN DEFICIENCY; LIPOPROTEIN METABOLISM; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SILENT GENE; WILD TYPE;

APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; ARYLDIALKYLPHOSPHATASE; CARRIER PROTEINS; CHILD, PRESCHOOL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; FEMALE; GLYCOPROTEINS; HETEROZYGOTE; HUMANS; LIPOPROTEIN LIPASE; MALE; PEDIGREE;

EID: 3943060088     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2004.01360.x     Document Type: Article

References (40)

1. Strauss JG, Frank S, Kratky D, Hämmerle G, Hrzenjak A, Knipping G et al. Adenovirus-mediated rescue of lipoprotein lipase-deficient mice. J Biol Chem 2001;276:36083-90.
2. Santamarina-Fojo S, Dugi KA. Structure, function and role of lipoprotein lipase in lipoprotein metabolism. Curr Opin Lipidol 1994;5:117-25.
3. Dolphin PJ. Lipolytic enzymes and the role of apolipoproteins in the regulation of their activity. In: Rosseneu M, editor. Structure and Function of Apolipoproteins. London: CRC Press; 1992.pp.297-316.
4. Hill JS, Yang D, Nikazy J, Curtiss LK, Sparrow JT, Wong H. Subdomain chimeras of hepatic lipase and lipoprotein lipase. J Biol Chem 1998;273:30979-84.
5. Ikeda Y, Takagi A, Nakata Y, Sera Y, Hyoudou S, Hamamoto K et al. Novel compound heterozygous mutations for lipoprotein lipase deficiency: a G-to-T transversion at the first position of exon 5 causing G154V missense mutation and a 5′ splice site mutation of intron 8. J Lipid Res 2001;42:1072-81.
6. Patsch JR, Miesenböck G, Hopferwieser T, Mühlberger V, Knapp E, Dünn JK et al. Relation of triglyceride metabolism and coronary artery disease. Arterioscler Thromb 1992;12:1336-45.
7. Brites FD, Bonavita CD, De Geitere C, Cloës M, Delfly B, Yael MJ et al. Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels. Atherosclerosis 2000;152:181-92.
8. Brites FD, Cavallero E, De Geitere C, Nicolaïew NL, Jacotot B, Rosseneu M et al. Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-β particle in type 2 diabetic patients. Clin Chim Acta 1999;279:1-14.
9. Glomset JA. The plasma lecithin: cholesterol acyltransferase reaction. J Lipid Res 1968;9:155-67.
10. Basso F, Freeman L, Knapper CL, Remaley A, Stonik J, Neufeld EB et al. Role of hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations. J Lipid Res 2003;44:296-302.
11. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995;36:211-28.
12. Stein O, Stein Y. Atheroprotective mechanisms of HDL. Atherosclerosis 1999;44:285-303.
13. Steinberg S, Parthasarathy D, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low density lipoproteins that increase its atherogenicity. N Engl J Med 1989;320:915-24.
14. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM et al. Protective effect of high density lipoprotein associated paraoxonase. J Clin Invest 1995;96:2882-91.
15. Brites F, Henriksen F, Fernández K, Brusgaard K, Castro G, Wikinski R. New mutations in the lipoprotein lipase gene in a young boy with chylomicronemia syndrome and in his family. Acta Paediatrica 2003;92:621-4.
16. Peterson J, Fujimoto WY, Brunzell JD. Human lipoprotein lipase: relationship of activity, heparin affinity, and conformation as studied with monoclonal antibodies. J Lipid Res 1992;33:1165-70.
17. Bengtsson-Olivecrona G, Olivecrona T. Assay of lipoprotein lipase and hepatic lipase. In: Converse CA, Skinner ER, editors. Lipoprotein Analysis: a Practical Approach. Oxford: Oxford University Press; 1992,pp.169-85.
18. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982;28:1379-88.
19. Rosental SB, Brites F, Wikinski R. Assessment of high density lipoprotein cholesterol in hypertriglyceridemic sera. Clin Chem 1993;39:1350-2.
20. Assmann G, Jabs HU, Kohnert U, Nolte W, Schriewer H. LDL (low-density-lipoprotein) cholesterol determination in blood serum following precipitation of LDL with poly (vinil sulphate). Clin Chim Acta 1984;140:77-83.
21. Bartlett GR. Phosphorus assay column chromatography. J Biol Chem 1959;234:466-8.
22. Okazaki M, Sasamoto K, Muramatsu T, Hosaki S. Analysis of Plasma Lipoproteins by Gel Permeation Chromatography. In: Rifai N, Warnick GR et al. editors. 1997,pp.531-48.
23. De la Llera Moya M, Atger V, Paul JL, Fournier N, Moatti N, Giral P et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Arterioscler Thromb 1994;14:1056-65.
24. Chen CH, Albers JJ. Characterization of proteoliposomes containing apoprotein A-I. a new substrate for the measurement of lecithin: cholesterol acyltransferace activity. J Lipid Res 1982;23:680-91.
25. Lagrost L, Gandjini H, Athias A, Guyard-Dangremont V, Lallemant C, Gambert P. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Arterioscler Thromb 1993;13:815-25.
26. Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-β-migrating high density lipoprotein. Biochemistry 1988;27:25-9.
27. Furlong CE, Richter RJ, Seidel SL, Costa LG, Motulsky AG. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of clorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 1989;180:242-7.
28. Blank ML, Hall MN, Cress AE, Snider F. Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats. Biochem Biophys Res Commun 1983;113:666-71.
29. Chan L, Mak Y, Tomlinson B, Baum L, Wu X, Masarei J et al. Compound heterozygosity of Leu252Val and Leu252Arg causing lipoprotein lipase deficiency in a Chinese patient with hypertriglyceridemia. Eur J Clin Invest 2000;30:33-40.
30. Fournier N, Paul JL, Atger V, Cogny A, Soni T, de la Llera-Moya M et al. HDL phospholipid content and composition as a mayor factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol 1997;17:2685-91.
31. Cavallero E, Brites F, Delfly B, Decossin C, Nic olaïew N, De Geitere C et al. Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies in fasting and postprandial LpA-I particles. Arterioscler Thromb Vasc Biol 1995;15:2130-5.
32. Brousseau ME, Eberhart GP, Dupuis J, Asztalos BF, Goldkamp AL, Schaefer EJ et al. Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size. J Lipid Res 2000;41:1125-35.
33. Barter PCETP, atherosclerosis. Arterioscler Thromb Vasc Biol 2000;20:2029-31.
34. Zilversmit DB. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem 1995;41:153-8.
35. Blatter MC, James RW, Messmer S, Barja F, Pometta D. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem 1993;211:871-9.
36. Caslake MJ, Packard CJ, Suckling KE, Holmes SD, Chamberlain P, Macphee CH et al. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. Atherosclerosis 2000;150:413-9.
37. Hayden MR, Ma Y, Brunzell JD, Henderson HE. Genetic variants affecting human lipoprotein and hepatic lipases. Curr Opin Lipidol 1991;2:104-9.
38. Faustinella F, Chang A, Van Biervliet JP, Rosseneu M, Vinaimont N, Smith LC et al. Catalytic triad residue mutation (Asp156Gly) causing familial lipoprotein lipase deficiency. Coinheritance with a nonsense mutation (Ser447Ter) in a Turkish family. J Biol Chem 1991;266:14418-24.
39. Hata A, Robertson M, Emi M, Lalouel JM. Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucl Acids Res 1990;18:5407-11.
40. Stocks J, Thorn JA, Galton DJ. Lipoprotein lipase genotypes for a common premature termination codon mutation detected by PCR-mediated site-directed mutagenesis and restriction digestion. J Lipid Res 1992;33:853-7.